Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

New targets on the horizon

POLTheta inhibitors and USP1 inhibitors for BRCA-deficient cancers

Date

21 Oct 2023

Session

New targets on the horizon

Topics

Tumour Site

Ovarian Cancer;  Breast Cancer

Presenters

Alan D'Andrea

Authors

A. D'Andrea

Author affiliations

  • Dana Farber Cancer Institute, 02215 - Boston/US

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.